시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
의약품 현탁액 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 유통 채널별, 최종 사용자별, 적응증별, 지역별, 전망 및 예측(2023-2030년)
Global Pharmaceutical Suspension Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End User, By Indication, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1432682
리서치사 : KBV Research
발행일 : 2024년 02월
페이지 정보 : 영문 304 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,341,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,409,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,973,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

제약 현탁액 시장 규모는 2030년까지 746억 달러에 달할 것으로 예상되며, 예측 기간 동안 4.0%의 시장 성장률을 나타낼 전망입니다.

그러나 새로운 의약품 현탁액 개발에는 대규모 연구개발이 필요한 경우가 많습니다. 제형 최적화, 안정성 테스트 및 임상시험과 관련된 비용을 포함한 R&D 비용의 급증은 제약 회사의 재정을 압박할 수 있습니다. 복용량 및 맛의 맞춤화 등 특정 환자의 요구에 맞게 의약품 현탁액을 조정하는 것은 맞춤화 비용을 증가시킬 수 있습니다. 따라서 높은 비용은 시장 성장을 저해하는 큰 도전이 되고 있습니다.

또한, 노동력 부족, 노동력 봉쇄, 전 세계 여행 제한으로 인해 최종 제품의 이동과 원자재 수급에 악영향을 미쳐 부족과 지연이 발생했습니다. 코로나19는 제약업계 전반의 임상시험 활동에 혼란을 초래했습니다. 특히 재택 투여에 적합한 현탁액 제제는 의료 서비스 제공업체가 기존 의료 환경 밖에서도 쉽게 투여할 수 있는 환자 친화적인 제형을 요구함에 따라 그 중요성이 더욱 커졌습니다. 이처럼 코로나19 팬데믹은 시장에 적당한 영향을 미쳤습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요약

제3장 시장 개요

제4장 의약품 현탁액 시장에서 전개하는 전략

제5장 세계 시장 : 유형별

제6장 세계 시장 : 유통 채널별

제7장 세계 시장 : 최종사용자별

제8장 세계 시장 : 적응증별

제9장 세계 시장 : 지역별

제10장 기업 개요

제11장 의약품 현탁액 시장을 위한 성공 필수 조건

LSH
영문 목차

영문목차

The Global Pharmaceutical Suspension Market size is expected to reach $74.6 billion by 2030, rising at a market growth of 4.0% CAGR during the forecast period.

Pharmaceutical suspensions can improve the bioavailability of drugs, especially those with low solubility. In the gastrointestinal segment, where absorption is critical, suspensions enable better drug dissolution, leading to increased absorption and enhanced therapeutic efficacy. Consequently, the gastrointestinal segment would generate approximately 13.76% share of the market by 2030. Gastrointestinal pharmaceutical suspensions can be formulated in various dosage forms, including liquids, powders, or effervescent formulations. This versatility allows for forming formulations tailored to patient preferences and specific therapeutic requirements, contributing to a diverse product portfolio.

Telemedicine enables healthcare professionals to manage and monitor patients' medication regimens remotely. With their adaptability and ease of administration, pharmaceutical suspensions provide convenient options for patients who participate in telemedicine consultations and require remote medication management. Telemedicine services are often integrated with home medication delivery services. Therefore, the market is expanding significantly due to the expansion of telemedicine services. Moreover, Patient-centric healthcare emphasizes strategies to enhance medication adherence. With their palatable nature and ease of administration, pharmaceutical suspensions improve adherence as patients find these formulations more acceptable and easier to integrate into their daily routines. Patient education is a key component of patient-centric care. Thus, because of the increasing patient-centric healthcare trends, the market is anticipated to increase significantly

However, The development of new pharmaceutical suspensions often involves extensive research and development efforts. High R&D expenses, including costs related to formulation optimization, stability studies, and clinical trials, can strain the financial resources of pharmaceutical companies. Tailoring pharmaceutical suspensions to meet specific patient needs, such as personalized dosage strengths or flavors, can increase customization costs. Therefore, high-cost implications are a significant challenge that hampers the growth of market.

Furthermore, The movement of finished products and the accessibility of raw materials were adversely impacted by labor shortages, labor lockdowns, and restrictions on global travel, resulting in shortages and delays. The pandemic disrupted clinical trial activities across the pharmaceutical industry. Pharmaceutical suspensions, particularly those suitable for home administration, gained significance as healthcare providers sought patient-friendly dosage forms that can be easily administered outside traditional healthcare settings. Thus, the COVID-19 pandemic had a moderate effect on the market.

By Type Analysis

By type, the market is categorized into oral, parenteral, and others. The oral segment covered a considerable revenue share in the market in 2022. The oral segment is a key area for taste masking applications. Pharmaceutical suspensions allow for the addition of flavoring agents to mask the unpleasant taste of certain drugs. This is especially crucial in pediatrics, where taste can significantly impact medication adherence. By improving palatability, oral suspensions contribute to better patient acceptance. Oral pharmaceutical suspensions are used to develop extended-release formulations, providing controlled and sustained drug release. This is beneficial for chronic conditions that require continuous therapeutic effects and can reduce the frequency of administration.

By Distribution Channel Analysis

By distribution channel, the market is segmented into hospital pharmacies, drug store & retail pharmacies, online providers. In 2022, the drug store & retail pharmacies segment registered the maximum revenue share in the market. Pharmaceutical suspensions, especially those formulated for common ailments and symptoms, are often available over the counter in drug stores and retail pharmacies. This accessibility encourages self-care and empowers consumers to manage minor health issues without a prescription. Drug stores and retail pharmacies stock various medications for various therapeutic areas. Pharmaceutical suspensions, adaptable to different conditions such as coughs, colds, allergies, and gastrointestinal issues, contribute to the comprehensive offerings in these establishments.

By End-User Analysis

On the basis of end user, the market is divided into hospitals and clinics, home care settings, and others. The home care settings segment garnered a significant revenue share in the market in 2022. Pharmaceutical suspensions are typically liquid formulations, making them easy to administer, especially for patients with difficulty swallowing pills or capsules. In a home care setting, where self-administration or administration by family members is common, the liquid form of suspensions contributes to simplified and convenient dosing. Home care settings frequently involve managing chronic conditions requiring long-term medication. Pharmaceutical suspensions, particularly sustained-release formulations, offer a convenient option for patients to self-administer medications at home, reducing the need for frequent healthcare facility visits.

By Indication Analysis

Based on indication, the market is classified into infectious diseases, cancer, gastrointestinal, neurological, and others. In 2022, the cancer segment witnessed the largest revenue share in the market. Cancer treatment often involves combination therapies using multiple drugs. Pharmaceutical suspensions enable the formulation of combination therapies in a single dosage form. This simplifies administration, improves patient adherence, and provides a comprehensive approach to cancer treatment. As new and innovative cancer therapies emerge, pharmaceutical suspensions provide a suitable platform for their development and delivery. This adaptability supports the growth of the market as it aligns with the evolving landscape of cancer treatment.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a significant revenue share in the market. The Asia Pacific region's growing population leads to increased healthcare needs. The Asia Pacific region has a significant proportion of pediatric and geriatric populations. The prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and respiratory disorders, is on the rise in the Asia Pacific region. The Asia Pacific region is increasingly focusing on specialty medications and personalized treatments. The rise of home healthcare services in the Asia Pacific region creates a demand for pharmaceutical formulations suitable for self-administration.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Pharmaceutical Suspension Market Report Segmentation

By Type

By Distribution Channel

By End User

By Indication

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Strategies Deployed in Pharmaceutical Suspension Market

Chapter 5. Global Pharmaceutical Suspension Market by Type

Chapter 6. Global Pharmaceutical Suspension Market by Distribution Channel

Chapter 7. Global Pharmaceutical Suspension Market by End User

Chapter 8. Global Pharmaceutical Suspension Market by Indication

Chapter 9. Global Pharmaceutical Suspension Market by Region

Chapter 10. Company Profiles

Chapter 11. Winning Imperatives of Pharmaceutical Suspension Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기